GlassScriptPhysician profile
Lindsey A Vallet
NPI 1457727018
$1,989.67
in general payments reported to CMS, 2019-2025
31 companies · $35.99 in 2025
The $35.99 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $507 · 2022: $624 · 2023: $467 · 2024: $356 · 2025: $35.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $858.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $339.07 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $284.67 | 2021-2023 | |
| Lilly USA, LLC | $153.13 | 2023-2024 | Zepbound, Mounjaro, Amyvid |
| Astellas Pharma US INC | $129.65 | 2021-2024 | Veozah |
| Idorsia Pharmaceuticals US INC | $122.42 | 2023-2024 | Quviviq |
| Daiichi Sankyo INC. | $112.62 | 2021-2022 | |
| Avion Pharmaceuticals | $98.86 | 2021-2022 | |
| Urovant Sciences INC | $89.72 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $84.00 | 2023-2024 | Nuedexta, Rexulti |
| Abbott Laboratories | $82.71 | 2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Therapeuticsmd, INC. | $67.99 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.10 | 2021-2022 | |
| Organon LLC | $39.73 | 2021-2025 | Nexplanon |
| Pfizer INC. | $33.47 | 2021 | |
| Lupin INC. | $32.18 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $30.72 | 2022-2023 | Contrave |
| Evofem Biosciences, INC. | $28.61 | 2021 | |
| Exact Sciences Corporation | $21.14 | 2023 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $19.43 | 2022 | |
| Exeltis, USA INC. | $19.18 | 2022 | |
| Hologic Sales and Service, LLC | $16.98 | 2021 | |
| Mylan Pharmaceuticals INC. | $15.75 | 2021 | |
| Tolmar, INC. | $15.57 | 2025 | Jatenzo |
| Corium, LLC | $15.11 | 2023 | Adlarity |
| Merck Sharp & Dohme LLC | $15.04 | 2023 | Verquvo, Belsomra |
| Coopersurgical, INC. | $14.12 | 2021 | |
| Amgen INC. | $14.11 | 2023 | Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $13.74 | 2023 | |
| Acella Pharmaceuticals, LLC | $13.36 | 2023 | NP Thyroid 60 |
| Mission Pharmacal Company | $13.10 | 2021 | |
| Agile Therapeutics, INC. | $12.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Vallet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.